ReachRxResearch
Home
Research
Sign Up
Performance of the recent Duke criteria versions in patients with suspected infective endocarditis and sufficient cardiac imaging: The more things change, the more they remain the same
Back to Research Hub
  1. Home
  2. Research Hub
  3. Performance of the recent Duke criteria…

Performance of the recent Duke criteria versions in patients with suspected infective endocarditis and sufficient cardiac imaging: The more things change, the more they remain the same

Clinical Infectious Diseases·October 29Open Access
Infectious DiseasesConfirms priorInfective EndocarditisRetrospective Cohort StudyDiagnostic CriteriaMultimodality Cardiac ImagingAdult

Summary

View source

What was studied

Diagnostic performance of three versions of the Duke criteria (2015 Duke-ESC, 2023 Duke-ISCVID, 2023 Duke-ESC) for infective endocarditis (IE) was compared in 3,448 adult episodes of suspected IE at two Swiss university hospitals (2014–2025) where guideline-concordant multimodality cardiac imaging had been performed.

Key findings

Both 2023 criteria improved sensitivity for definite IE (2015 Duke-ESC: 63%; 2023 Duke-ISCVID: 74%; 2023 Duke-ESC: 71%) but at the cost of lower specificity (72% → 59% and 66%, respectively); approximately one-third of cases remained in the diagnostic gray-zone of 'possible' IE across all three criteria versions.

Study limitations

Retrospective design at two Swiss tertiary centers limits generalizability; the reference standard (Endocarditis Team adjudication) is itself subject to expert bias; the cohort is enriched for patients who already received guideline-concordant imaging, so performance may differ in lower-resource or lower-acuity settings.

Clinical implications

Even with optimal multimodality cardiac imaging, the 2023 Duke criteria updates do not resolve the persistent 'possible' IE category (~29–33% of cases), so clinicians should not rely on criteria classification alone and must continue to exercise individualized clinical judgment for diagnostically uncertain cases.

Caveats

  • All patients had already undergone guideline-concordant multimodality cardiac imaging, which is not universally available — sensitivity and specificity may be lower in real-world practice where imaging is incomplete
  • The 'possible' IE category remained large (29–33%) even under ideal imaging conditions, meaning these criteria should not be used as a sole decision-making tool for treatment initiation or exclusion
  • The study was conducted exclusively at two Swiss tertiary university hospitals, limiting applicability to community or non-European settings

Related Questions

Explore related topics

How does multimodality cardiac imaging (TTE, TEE, CT, PET) affect infective endocarditis diagnosis rates?What is the clinical outcome of patients classified as 'possible' infective endocarditis by Duke criteria?How do the 2023 ISCVID and 2023 ESC Duke criteria compare in prosthetic valve and device-related endocarditis?

Publication Details

Year
2026
Journal
Clinical Infectious Diseases
Sample Size
n=3,448
Source
View article
Keep scrolling
More content below.
Up Next